STIs Flashcards
STI syndromes
Genital discharge
Genital warts/ulcers
Pelvic pain
Sexually transmitted and blood-borne viruses
Risk factors
Young age No barrier contraception Non-regular sexual relationships Men who have sex with men IV drug use African origin Social deprivation Sex workers Poor access to advice and treatment of STIs
Determinants of risky sexual behaviour
Individual factors - low self esteem, lack of skills and knowledge of risks of unsafe sex
External influences - peer pressure, attitudes and prejudices of society
Service provision - accessibility of sexual health services and/or lack of resources such as condoms
NAATs lab investigation
Nucleic acid amplification testing
Rely on detection of DNA
Used for Chlamydia and N.gonnorhoea
PCR can also be used for herpes
Microscopy, culture and sensitivity lab investigation
For N.gonorrhoeae, candida, bacterial vaginosis (BV), trichomonas vaginalis
Charcoal swab the medium used for gonoccoi (but also useful for transporting other organisms)
Blood test lab investigation
Syphilis, HIV, hepatitis
Chlamydia trachomatis - symptoms and complications
Obligate, intracellular, Gram -ve
Symptoms include discharge, tenderness, infertility in women, Relter’s syndrome (arthritis, cervicitis, urethritis, conjunctivitis), proctitis (inflamm of inner rectum), pharyngitis, perihepatitis (upper abdom pain)
Complicatios include PID (if symptomatic then infertility, ectopic preg, chronic pelvic pain, sexually acquired reactive arthritis, epididymo-orchitis, peri-hepatitis
Neonatal chlamydia
Manifests as conjuctivitis 5-12 days after birth or pneumonia 1-3 months
treat with oral erythromycin
Chlamydia investigations and treatment
Women - VVS swab taken
Men - first catch urine (FCU)
Extra genital sites - rectal/pharyngeal
Treatment - doxy 100mg bd for 7 days
Avoid sexual contact for duration of tx, partner notification
LGV
Lymphogranuloma venerum
Caused by one of three invasive serovars of chlamydia trachomatis
Presents as solitary genital lesion, proctitis, lymphadanopathy
Tx - doxy
Neisseria gonnorrhoeae bacteria
Gram -ve
Intracellular diplococcus
Humans only host
Infects epithelial cells of mucous membrane of GU tract or rectum
Development of localised infection with pus production
Possible asymptomatic carriage in women
Gonorrhoea symptoms
Penile urethral infection (90% symptomatic), discharge
Female urethral infection - dysuria +/- frequency
Endocervical infection - 50% increased/altered vaginal discharge, 25% lower abdom pain, occasionally inter-menstrual bleeding
Rectal - mostly asymptomatic but can present with anal discharge/pain/discomfort
Pharyngeal - mostly asymptomatic but can present with sore throat
Gonorrhoea lab diagnosis
Light microscopy of gram-stained genital specimens to look for gram -ve diplococci
NAAT - can use urine or swabs
PMN in urethral pus
men - first pass urine
women - Vulvo-vaginal swab
MSM - rectal and pharyngeal swabs as routine
Gonorrhoea tx
One of following:
Ceftriaxone 1g IM
Cipro 500mg orally
Most strains respond to ceftriaxone
Doxy also given to pts who have concomitant chlamydial infection
Partner notification - all partners within preceding two weeks
Partner tx - if >14d after exposure test and tx if +ve, if <14d then clinical risk assessment +/- abx
Test of cure - NAAT if asymptomatic
Bacterial vaginosis
Most common cause of abnormal vaginal discharge in women of child bearing age
Overgrowth of lactobacilli
RF’s - black ethnicity, receptive cunnilingus
Presentation - offensive fishy odour without itch/irritation
Diagnosis - microscopy
Tx - metronidazole